The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population

被引：0
作者：
Haofei Hu
Yong Han
Changchun Cao
Yongcheng He
机构：
[1] The First Affiliated Hospital of Shenzhen University,Department of Nephrology
[2] Shenzhen Second People’s Hospital,Department of Nephrology
[3] Shenzhen Second People’s Hospital,Department of Emergency
[4] The First Affiliated Hospital of Shenzhen University,Department of Emergency
[5] Shenzhen University Health Science Center,Department of Rehabilitation
[6] Shenzhen Dapeng New District Nan’ao People’s Hospital,Department of Nephrology
[7] Shenzhen Hengsheng Hospital,undefined
来源：
Journal of Translational Medicine | / 20卷
关键词：
Non-alcoholic fatty liver disease; Triglyceride glucose-body mass index; Negative predictive value; Receiver operating characteristic; Positive predictive value;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 460 条
[1]  
Rinella ME(2015)Nonalcoholic fatty liver disease: a systematic review JAMA 313 2263-2273
[2]  
Raj H(2019)SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: a systematic review World J Diabetes 10 114-132
[3]  
Durgia H(2011)Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults Aliment Pharmacol Ther 34 274-285
[4]  
Palui R(2016)The natural course of non-alcoholic fatty liver disease Int J Mol Sci 17 774-57
[5]  
Kamalanathan S(2021)Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: histological perspective Clin Mol Hepatol 27 44-602
[6]  
Selvarajan S(2010)Decreased survival of subjects with elevated liver function tests during a 28-year follow-up Hepatology 51 595-1927
[7]  
Kar SS(2019)The Natural history of advanced fibrosis due to nonalcoholic steatohepatitis: data from the simtuzumab trials Hepatology 70 1913-S64
[8]  
Sahoo J(2015)NAFLD: a multisystem disease J Hepatol 62 S47-1153
[9]  
Vernon G(2017)Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases Gut 66 1138-2192
[10]  
Baranova A(2019)Extra-hepatic manifestations and complications of nonalcoholic fatty liver disease Future Med Chem 11 2171-C80
12345678910